Migraine: Possible role of shear-induced platelet aggregation with serotonin release

Headache

Volumn 52, Issue 8, 2012, Pages 1298-1318

  Borgdorff, Piet ^a   Tangelder, Geert Jan ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

clopidogrel; hypothesis; migraine; platelet aggregation; serotonin; shear stress

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CATECHOLAMINE; CLOPIDOGREL; CYCLOOXYGENASE 2 INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; ESTROGEN; GLYCOPROTEIN IB; HEMOGLOBIN; NEUROPEPTIDE; NITRIC OXIDE; PICOTAMIDE; PIZOTIFEN; POLYVINYLCHLORIDE; PROSTACYCLIN; PROSTAGLANDIN; PURINERGIC P2Y12 RECEPTOR; RIBOFLAVIN; SEROTONIN; THROMBOXANE; TICLOPIDINE; VON WILLEBRAND FACTOR; XENON 133;

AORTA PRESSURE; ARTERY DIAMETER; ARTERY SPASM; BLOOD BRAIN BARRIER; BLOOD FLOW VELOCITY; BRAIN BLOOD FLOW; BRAIN CIRCULUS ARTERIOSUS; BRAIN HYPOXIA; BRAIN MICROCIRCULATION; CACAO; CALCIUM CELL LEVEL; CAROTID ARTERY OBSTRUCTION; DISEASE ASSOCIATION; DRUG MEGADOSE; HEMODYNAMICS; HORMONE SUBSTITUTION; HUMAN; HYPEREMIA; MENSTRUAL MIGRAINE; MIGRAINE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; NEUROIMAGING; NOCICEPTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; PATENT FORAMEN OVALE; POSITRON EMISSION TOMOGRAPHY; POSTMENOPAUSE; PRIORITY JOURNAL; REVIEW; SEROTONIN BLOOD LEVEL; SEROTONIN RELEASE; SHEAR STRESS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; VAGUS NERVE; VASOCONSTRICTION; VASODILATATION;

ANIMALS; BLOOD PLATELETS; DISEASE MODELS, ANIMAL; MIGRAINE DISORDERS; PLATELET AGGREGATION; RATS; SEROTONIN;

EID: 84865861093     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2012.02162.x     Document Type: Review

References (213)

1. Kelman L,. The triggers or precipitants of the acute migraine attack. Cephalalgia. 2007; 27: 394-402.
2. Spector JT, Kahn SR, Jones MR, Jayakumar M, Dalal D, Nazarian S,. Migraine headache and ischemic stroke risk: An updated meta-analysis. Am J Med. 2010; 123: 612-624.
3. Dohmen C, Sakowitz OW, Fabricius M, et al,. Spreading depolarizations occur in human ischemic stroke with high incidence. Ann Neurol. 2008; 63: 720-728.
4. Kruit MC, Launer LJ, Ferrari MD, van Buchem MA,. Infarcts in the posterior circulation territory in migraine. The population-based MRI CAMERA study. Brain. 2005; 128: 2068-2077.
5. Hanington E,. Migraine. A platelet hypothesis. Biomedicine. 1979; 30: 65-66.
6. Borgdorff P, Kok WE, Vis MA, van den Bos GC,. Vasodilation by shear-induced platelet aggregation in extracorporeal circuits. Am J Physiol. 1994; 266: H891-H897.
7. Borgdorff P, van Den Berg RH, Vis MA, van den Bos GC, Tangelder GJ,. Pump-induced platelet aggregation in albumin-coated extracorporeal systems. J Thorac Cardiovasc Surg. 1999; 118: 946-952.
8. Borgdorff P, Fekkes D, Tangelder GJ,. Hypotension caused by extracorporeal circulation: Serotonin from pump-activated platelets triggers nitric oxide release. Circulation. 2002; 106: 2588-2593.
9. Borgdorff P, Tangelder GJ,. Pump-induced platelet aggregation with subsequent hypotension: Its mechanism and prevention with clopidogrel. J Thorac Cardiovasc Surg. 2006; 131: 813-821.
10. Borgdorff P, Tangelder GJ, Paulus WJ,. Cyclooxygenase-2 inhibitors enhance shear stress-induced platelet aggregation. J Am Coll Cardiol. 2006; 48: 817-823.
11. Borgdorff P, Handoko ML, Wong YY, Tangelder GJ,. COX-2 inhibition by use of rofecoxib or high dose aspirin enhances ADP-induced platelet aggregation in fresh blood. Open Cardiovasc Med J. 2010; 4: 198-205.
12. D'Andrea G, Toldo M, Cananzi A, Ferro-Milone F,. Study of platelet activation in migraine: Control by low doses of aspirin. Stroke. 1984; 15: 271-275.
13. Fujita S,. Effects of correcting platelet hyper-aggregability on prevention of migraine with aura manifested by scintillating scotoma and on migraine outcome using the MIDAS scale. Headache Care. 2006; 3: 65-72.
14. Peto R, Gray R, Collins R, et al,. Randomised trial of prophylactic daily aspirin in British male doctors. Br Med J (Clin Res Ed). 1988; 296: 313-316.
15. Kirthi V, Derry S, Moore RA, McQuay HJ,. Aspirin with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev. 2010;(14):CD008041.
16. Lampl C, Voelker M, Diener HC,. Efficacy and safety of 1000 mg effervescent aspirin: Individual patient data meta-analysis of three trials in migraine headache and migraine accompanying symptoms. J Neurol. 2007; 254: 705-712.
17. Ferrari MD, Saxena PR,. On serotonin and migraine: A clinical and pharmacological review. Cephalalgia. 1993; 13: 151-165.
18. Izzati-Zade KF,. The role of serotonin in the pathogenesis and clinical presentations of migraine attacks. Neurosci Behav Physiol. 2008; 38: 501-505.
19. Evers S, Quibeldey F, Grotemeyer KH, Suhr B, Husstedt IW,. Dynamic changes of cognitive habituation and serotonin metabolism during the migraine interval. Cephalalgia. 1999; 19: 485-491.
20. Davis RB, Wang Y,. Rapid pulmonary removal of 5-hydroxytryptamine in the intact dog. Proc Soc Exp Biol Med. 1965; 118: 797-800.
21. Lance JW,. 5-Hydroxytryptamine and its role in migraine. Eur Neurol. 1991; 31: 279-281.
22. Panconesi A, Sicuteri R,. Headache induced by serotonergic agonists-a key to the interpretation of migraine pathogenesis? Cephalalgia. 1997; 17: 3-14.
23. Sommer C,. Serotonin in pain and analgesia: Actions in the periphery. Mol Neurobiol. 2004; 30: 117-125.
24. Clower BR, Sullivan DM, Smith RR,. Intracranial vessels lack vasa vasorum. J Neurosurg. 1984; 61: 44-48.
25. Koo JW, Balaban CD,. Serotonin-induced plasma extravasation in the murine inner ear: Possible mechanism of migraine-associated inner ear dysfunction. Cephalalgia. 2006; 26: 1310-1319.
26. Sarchielli P, Alberti A, Codini M, Floridi A, Gallai V,. Nitric oxide metabolites, prostaglandins and trigeminal vasoactive peptides in internal jugular vein blood during spontaneous migraine attacks. Cephalalgia. 2000; 20: 907-918.
27. Christiansen I, Thomsen LL, Daugaard D, Ulrich V, Olesen J,. Glyceryl trinitrate induces attacks of migraine without aura in sufferers of migraine with aura. Cephalalgia. 1999; 19: 660-667.
28. Wienecke T, Olesen J, Ashina M,. Prostaglandin I(2) (epoprostenol) triggers migraine-like attacks in migraineurs. Cephalalgia. 2010; 30: 179-190.
29. Lassen LH, Ashina M, Christiansen I, et al,. Nitric oxide synthase inhibition: A new principle in the treatment of migraine attacks. Cephalalgia. 1998; 18: 27-32.
30. Jakubowski M, Levy D, Goor-Aryeh I, Collins B, Bajwa Z, Burstein R,. Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of COX1/COX2 inhibitors. Headache. 2005; 45: 850-861.
31. Reuter U, Bolay H, Jansen-Olesen I, et al,. Delayed inflammation in rat meninges: Implications for migraine pathophysiology. Brain. 2001; 124: 2490-2502.
32. Akerman S, Williamson DJ, Kaube H, Goadsby PJ,. Nitric oxide synthase inhibitors can antagonize neurogenic and calcitonin gene-related peptide induced dilation of dural meningeal vessels. Br J Pharmacol. 2002; 137: 62-68.
33. Anthony M, Hinterberger H, Lance JW,. Plasma serotonin in migraine and stress. Arch Neurol. 1967; 16: 544-552.
34. Moskowitz MA,. Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine. Trends Pharmacol Sci. 1992; 13: 307-311.
35. Ikeda Y, Jimbo H, Shimazu M, Satoh K,. Sumatriptan scavenges superoxide, hydroxyl, and nitric oxide radicals: In vitro electron spin resonance study. Headache. 2002; 42: 888-892.
36. Buzzi MG, Moskowitz MA,. The pathophysiology of migraine: Year 2005. J Headache Pain. 2005; 6: 105-111.
37. Tfelt-Hansen PC,. History of migraine with aura and cortical spreading depression from 1941 and onwards. Cephalalgia. 2010; 30: 780-792.
38. Skyhoj OT,. Migraine with and without aura: The same disease due to cerebral vasospasm of different intensity. A hypothesis based on CBF studies during migraine. Headache. 1990; 30: 269-272.
39. Skyhoj OT, Friberg L, Lassen NA,. Ischemia may be the primary cause of the neurologic deficits in classic migraine. Arch Neurol. 1987; 44: 156-161.
40. Amery WK,. Brain hypoxia: The turning-point in the genesis of the migraine attack? Cephalalgia. 1982; 2: 83-109.
41. Leao AAP,. Further observations on the spreading depression of activity in the cerebral cortex. J Neurophysiol. 1947; 10: 409-414.
42. Marcussen RM, Wolff HG,. Effects of carbon dioxide-oxygen mixtures given during preheadache phase of the migraine attack; further analysis of the pain mechanisms in headache. Arch Neurol Psychiatry. 1950; 63: 42-51.
43. Nozari A, Dilekoz E, Sukhotinsky I, et al,. Microemboli may link spreading depression, migraine aura, and patent foramen ovale. Ann Neurol. 2010; 67: 221-229.
44. Satoh S, Suzuki Y, Harada T, et al,. The role of platelets in the development of cerebral vasospasm. Brain Res Bull. 1991; 27: 663-668.
45. Schoonman GG, van der GJ, Kortmann C, van der Geest RJ, Terwindt GM, Ferrari MD,. Migraine headache is not associated with cerebral or meningeal vasodilatation-A 3T magnetic resonance angiography study. Brain. 2008; 131: 2192-2200.
46. Asghar MS, Hansen AE, Amin FM, et al,. Evidence for a vascular factor in migraine. Ann Neurol. 2011; 69: 635-645.
47. Norris JW, Hachinski VC, Cooper PW,. Changes in cerebral blood flow during a migraine attack. Br Med J. 1975; 3: 676-677.
48. Skinhoj E,. Hemodynamic studies within the brain during migraine. Arch Neurol. 1973; 29: 95-98.
49. Skinhoj E, Paulson OB,. Regional blood flow in internal carotid distribution during migraine attack. Br Med J. 1969; 3: 569-570.
50. Hachinski VC, Olesen J, Norris JW, Larsen B, Enevoldsen E, Lassen NA,. Cerebral hemodynamics in migraine. Can J Neurol Sci. 1977; 4: 245-249.
51. Olesen J, Friberg L, Olsen TS, et al,. Timing and topography of cerebral blood flow, aura, and headache during migraine attacks. Ann Neurol. 1990; 28: 791-798.
52. Mathew NT, Hrastnik F, Meyer JS,. Regional cerebral blood flow in the diagnosis of vascular headache. Headache. 1976; 15: 252-260.
53. Olesen J, Tfelt-Hansen P, Henriksen L, Larsen B,. The common migraine attack may not be initiated by cerebral ischaemia. Lancet. 1981; 2: 438-440.
54. Bednarczyk EM, Remler B, Weikart C, Nelson AD, Reed RC,. Global cerebral blood flow, blood volume, and oxygen metabolism in patients with migraine headache. Neurology. 1998; 50: 1736-1740.
55. Wolff HG,. Headache mechanisms. Int Arch Allergy. 1955; 7: 210-278.
56. Rahmann A, Wienecke T, Hansen JM, Fahrenkrug J, Olesen J, Ashina M,. Vasoactive intestinal peptide causes marked cephalic vasodilation, but does not induce migraine. Cephalalgia. 2008; 28: 226-236.
57. Lauritzen M, Olesen J,. Regional cerebral blood flow during migraine attacks by Xenon-133 inhalation and emission tomography. Brain. 1984; 107: 447-461.
58. Ahn AH,. On the temporal relationship between throbbing migraine pain and arterial pulse. Headache. 2010; 50: 1507-1510.
59. Yip HK, Lu CH, Yang CH, et al,. Levels and value of platelet activity in patients with severe internal carotid artery stenosis. Neurology. 2006; 66: 804-808.
60. Siedlecki CA, Lestini BJ, Kottke-Marchant KK, Eppell SJ, Wilson DL, Marchant RE,. Shear-dependent changes in the three-dimensional structure of human von Willebrand factor. Blood. 1996; 88: 2939-2950.
61. McCrary JK, Nolasco LH, Hellums JD, Kroll MH, Turner NA, Moake JL,. Direct demonstration of radiolabeled von Willebrand factor binding to platelet glycoprotein Ib and IIb-IIIa in the presence of shear stress. Ann Biomed Eng. 1995; 23: 787-793.
62. Barstad RM, Orvim U, Hamers MJ, Tjonnfjord GE, Brosstad FR, Sakariassen KS,. Reduced effect of aspirin on thrombus formation at high shear and disturbed laminar blood flow. Thromb Haemost. 1996; 75: 827-832.
63. Cohen Z, Bonvento G, Lacombe P, Hamel E,. Serotonin in the regulation of brain microcirculation. Prog Neurobiol. 1996; 50: 335-362.
64. Fozard JR,. The 5-hydroxytryptamine-nitric oxide connection: The key link in the initiation of migraine? Arch Int Pharmacodyn Ther. 1995; 329: 111-119.
65. Blackshear JL, Orlandi C, Hollenberg NK,. Serotonin and the renal blood supply: Role of prostaglandins and the 5HT-2 receptor. Kidney Int. 1986; 30: 304-310.
66. Secil Y, Unde C, Beckmann YY, Bozkaya YT, Ozerkan F, Basoglu M,. Blood pressure changes in migraine patients before, during and after migraine attacks. Pain Pract. 2010; 10: 222-227.
67. Lechin F, Van Der Dijs B, Lechin AE,. Circulating serotonin, catecholamines, and central nervous system circuitry related to some cardiorespiratory, vascular, and hematological disorders. J Appl Res. 2005; 5: 605-621.
68. Lee RM,. Morphology of cerebral arteries. Pharmacol Ther. 1995; 66: 149-173.
69. Krabbe-Hartkamp MJ, van der GJ, de Leeuw FE, et al,. Circle of Willis: Morphologic variation on three-dimensional time-of-flight MR angiograms. Radiology. 1998; 207: 103-111.
70. Glor FP, Ariff B, Hughes AD, et al,. Influence of head position on carotid hemodynamics in young adults. Am J Physiol Heart Circ Physiol. 2004; 287: H1670-H1681.
71. Lal BK, Beach KW, Sumner DS,. Intracranial collateralization determines hemodynamic forces for carotid plaque disruption. J Vasc Surg. 2011; 54: 1461-1471.
72. Bugnicourt JM, Garcia PY, Peltier J, Bonnaire B, Picard C, Godefroy O,. Incomplete posterior circle of Willis: A risk factor for migraine? Headache. 2009; 49: 879-886.
73. Klingebiel R, Friedman A, Shelef I, Dreier JP,. Clearance of a status aurae migraenalis in response to thrombendarterectomy in a patient with high grade internal carotid artery stenosis. J Neurol Neurosurg Psychiatry. 2008; 79: 89-90.
74. Troost BT, Mark LE, Maroon JC,. Resolution of classic migraine after removal of an occipital lobe AVM. Ann Neurol. 1979; 5: 199-201.
75. Kurita H, Shin M, Kirino T,. Resolution of migraine with aura caused by an occipital arteriovenous malformation. Arch Neurol. 2000; 57: 1219-1220.
76. Kurita H, Ueki K, Shin M, et al,. Headaches in patients with radiosurgically treated occipital arteriovenous malformations. J Neurosurg. 2000; 93: 224-228.
77. Tuchin PJ, Pollard H, Bonello R,. A randomized controlled trial of chiropractic spinal manipulative therapy for migraine. J Manipulative Physiol Ther. 2000; 23: 91-95.
78. Martins IP, Parreira E,. Behavioral response to headache: A comparison between migraine and tension-type headache. Headache. 2001; 41: 546-553.
79. Schwedt TJ, Demaerschalk BM, Dodick DW,. Patent foramen ovale and migraine: A quantitative systematic review. Cephalalgia. 2008; 28: 531-540.
80. Domitrz I, Mieszkowski J, Kaminska A,. Relationship between migraine and patent foramen ovale: A study of 121 patients with migraine. Headache. 2007; 47: 1311-1318.
81. Post MC, van Gent MW, Plokker HW, et al,. Pulmonary arteriovenous malformations associated with migraine with aura. Eur Respir J. 2009; 34: 882-887.
82. Shahar E, Borenstein A, Filk D,. Severe migraine associated with coarctation of aorta: Complete recovery following balloon dilation. J Child Neurol. 2000; 15: 826-827.
83. Rundek T, Elkind MS, Di Tullio MR, et al,. Patent foramen ovale and migraine: A cross-sectional study from the Northern Manhattan Study (NOMAS). Circulation. 2008; 118: 1419-1424.
84. Garg P, Servoss SJ, Wu JC, et al,. Lack of association between migraine headache and patent foramen ovale. Results of a case-control study. Circulation. 2010; 121: 1406-1412.
85. Schwerzmann M, Wiher S, Nedeltchev K, et al,. Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology. 2004; 62: 1399-1401.
86. Dowson A, Mullen MJ, Peatfield R, et al,. Migraine Intervention With STARFlex Technology (MIST) trial: A prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation. 2008; 117: 1397-1404.
87. Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL,. Clopidogrel reduces migraine with aura after transcatheter closure of persistent foramen ovale and atrial septal defects. Heart. 2005; 91: 1173-1175.
88. Sharifi M, Dehghani M, Mehdipour M, Al-Bustami O, Emrani F, Burks J,. Intense migraines secondary to percutaneous closure of atrial septal defects. J Interv Cardiol. 2005; 18: 181-183.
89. Cesar JM, Garcia-Avello A, Vecino AM, Sastre JL, Alvarez-Cermeno JC,. Increased levels of plasma von Willebrand factor in migraine crisis. Acta Neurol Scand. 1995; 91: 412-413.
90. Couch JR, Hassanein RS,. Platelet aggregability in migraine. Neurology. 1977; 27: 843-848.
91. Lechner H, Ott E, Fazekas F, Pilger E,. Evidence of enhanced platelet aggregation and platelet sensitivity in migraine patients. Cephalalgia. 1985; 5 (Suppl. 2): 89-91.
92. Kovacs K, Herman F, Filep J, Jelencsik I, Magyar K, Csanda E,. Platelet aggregation of migraineurs during and between attacks. Cephalalgia. 1990; 10: 161-165.
93. Kruglak L, Nathan I, Korczyn AD, Zolotov Z, Berginer V, Dvilansky A,. Platelet aggregability, disaggregability and serotonin uptake in migraine. Cephalalgia. 1984; 4: 221-225.
94. Hanington E, Jones RJ, Amess JA, Wachowicz B,. Migraine: A platelet disorder. Lancet. 1981; 2: 720-723.
95. Hsu LK, Crisp AH, Kalucy RS, et al,. Early morning migraine. Nocturnal plasma levels of catecholamines, tryptophan, glucose, and free fatty acids and sleep encephalographs. Lancet. 1977; 1: 447-451.
96. Tofler GH, Brezinski D, Schafer AI, et al,. Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Engl J Med. 1987; 316: 1514-1518.
97. Pattichis K, Louca LL, Jarman J, Sandler M, Glover V,. 5-hydroxytryptamine release from platelets by different red wines: Implications for migraine. Eur J Pharmacol. 1995; 292: 173-177.
98. Mezei Z, Kis B, Gecse A, et al,. Platelet arachidonate cascade of migraineurs in the interictal phase. Platelets. 2000; 11: 222-225.
99. Puig-Parellada P, Planas JM, Gimenez J, et al,. Plasma and saliva levels of PGI2 and TXA2 in the headache-free period of classical migraine patients. The effects of nicardipine. Headache. 1991; 31: 156-158.
100. Hedman C, Winther K, Knudsen JB,. Platelet function in classic migraine during attack-free periods. Acta Neurol Scand. 1988; 78: 271-277.
101. den Dekker E, Gorter G, Heemskerk JW, Akkerman JW,. Development of platelet inhibition by cAMP during megakaryocytopoiesis. J Biol Chem. 2002; 277: 29321-29329.
102. Inoue T, Hayashi M, Uchida T, Takayanagi K, Hayashi T, Morooka S,. Significance of platelet aggregability immediately after blood sampling and effect of cigarette smoking. Platelets. 2001; 12: 415-418.
103. Schramm DD, Wang JF, Holt RR, et al,. Chocolate procyanidins decrease the leukotriene-prostacyclin ratio in humans and human aortic endothelial cells. Am J Clin Nutr. 2001; 73: 36-40.
104. Zoladz JA, Majerczak J, Duda K, Chlopicki S,. Exercise-induced prostacyclin release positively correlates with VO(2max) in young healthy men. Physiol Res. 2009; 58: 229-238.
105. Pirich C, Efthimiou Y, O'Grady J, Zielinski C, Sinzinger H,. Apolipoprotein A and biological half-life of prostaglandin I2 in HIV-1 infection. Thromb Res. 1996; 81: 213-218.
106. Pirich C, Efthimiou Y, O'Grady J, Sinzinger H,. Hyperalphalipoproteinemia and prostaglandin I2 stability. Thromb Res. 1997; 88: 41-49.
107. Toth B, Nikolajek K, Rank A, et al,. Gender-specific and menstrual cycle dependent differences in circulating microparticles. Platelets. 2007; 18: 515-521.
108. Silberstein SD,. Sex hormones and headache. Rev Neurol (Paris). 2000; 156 (Suppl. 4): 4S30-4S41.
109. Gaglia MA Jr, Waksman R,. Overview of the 2010 food and drug administration cardiovascular and renal drugs advisory committee meeting regarding ticagrelor. Circulation. 2011; 123: 451-456.
110. Boudoulas KD, Cooke GE, Roos CM, Bray PF, Goldschmidt-Clermont PJ,. The PlA polymorphism of glycoprotein IIIa functions as a modifier for the effect of estrogen on platelet aggregation. Arch Pathol Lab Med. 2001; 125: 112-115.
111. Roberts JM, Goldfien RD, Tsuchiya AM, Goldfien A, Insel PA,. Estrogen treatment decreases alpha-adrenergic binding sites on rabbit platelets. Endocrinology. 1979; 104: 722-728.
112. Hayashi T, Yamada K, Esaki T, et al,. Estrogen increases endothelial nitric oxide by a receptor- mediated system. Biochem Biophys Res Commun. 1995; 214: 847-855.
113. Nakano Y, Oshima T, Matsuura H, Kajiyama G, Kambe M,. Effect of 17beta-estradiol on inhibition of platelet aggregation in vitro is mediated by an increase in NO synthesis. Arterioscler Thromb Vasc Biol. 1998; 18: 961-967.
114. Sobrino A, Oviedo PJ, Novella S, et al,. Estradiol selectively stimulates endothelial prostacyclin production through estrogen receptor-{alpha}. J Mol Endocrinol. 2010; 44: 237-246.
115. Granella F, Sances G, Zanferrari C, Costa A, Martignoni E, Manzoni GC,. Migraine without aura and reproductive life events: A clinical epidemiological study in 1300 women. Headache. 1993; 33: 385-389.
116. Amir BY, Yaacov B, Guy B, Gad P, Itzhak W, Gal I,. Headaches in women undergoing in vitro fertilization and embryo-transfer treatment. Headache. 2005; 45: 215-219.
117. Brandes JL,. The influence of estrogen on migraine: A systematic review. JAMA. 2006; 295: 1824-1830.
118. Aegidius K, Zwart JA, Hagen K, Schei B, Stovner LJ,. Oral contraceptives and increased headache prevalence: The Head-HUNT Study. Neurology. 2006; 66: 349-353.
119. Aegidius KL, Zwart JA, Hagen K, Schei B, Stovner LJ,. Hormone replacement therapy and headache prevalence in postmenopausal women. The Head-HUNT study. Eur J Neurol. 2007; 14: 73-78.
120. Norris LA, Bonnar J,. Effect of oestrogen dose on whole blood platelet activation in women taking new low dose oral contraceptives. Thromb Haemost. 1994; 72: 926-930.
121. Thijs A, Van Baal WM, Van Der Mooren MJ, et al,. Effects of hormone replacement therapy on blood platelets. Eur J Clin Invest. 2002; 32: 613-618.
122. Ylikorkala O, Puolakka J, Viinikka L,. Oestrogen containing oral contraceptives decrease prostacyclin production. Lancet. 1981; 1: 42.
123. Nappi RE, Sances G, Allais G, et al,. Effects of an estrogen-free, desogestrel-containing oral contraceptive in women with migraine with aura: A prospective diary-based pilot study. Contraception. 2011; 83: 223-228.
124. Ribeiro CA, Cotrim MD, Morgadinho MT, Ramos MI, Santos ES, de Macedo TR,. Migraine, serum serotonin and platelet 5-HT2 receptors. Cephalalgia. 1990; 10: 213-219.
125. Wingerchuk DM, Spencer B, Dodick DW, Demaerschalk BM,. Migraine with aura is a risk factor for cardiovascular and cerebrovascular disease: A critically appraised topic. Neurologist. 2007; 13: 231-233.
126. Sakai F, Igarashi H,. Prevalence of migraine in Japan: A nationwide survey. Cephalalgia. 1997; 17: 15-22.
127. Fukiyama K, Kimura Y, Wakugami K, Muratani H,. Incidence and long-term prognosis of initial stroke and acute myocardial infarction in Okinawa, Japan. Hypertens Res. 2000; 23: 127-135.
128. Lanzi G, Termine C, Rossi M, et al,. Are vascular disorders more prevalent in the relatives of children and adolescents with migraine? Cephalalgia. 2003; 23: 887-891.
129. Scher AI, Terwindt GM, Picavet HS, Verschuren WM, Ferrari MD, Launer LJ,. Cardiovascular risk factors and migraine: The GEM population-based study. Neurology. 2005; 64: 614-620.
130. Andersson KE, Vinge E,. Beta-adrenoceptor blockers and calcium antagonists in the prophylaxis and treatment of migraine. Drugs. 1990; 39: 355-373.
131. Neil-Dwyer G, Bartlett J, McAinsh J, Cruickshank JM,. Beta-adrenoceptor blockers and the blood-brian barrier. Br J Clin Pharmacol. 1981; 11: 549-553.
132. Edvinsson L, Johansson BB, Larsson B, MacKenzie ET, Skarby T, Young AR,. Calcium antagonists: Effects on cerebral blood flow and blood-brain barrier permeability in the rat. Br J Pharmacol. 1983; 79: 141-148.
133. Punda A, Polic S, Rumboldt Z, Bagatin J, Markovic V, Lukin A,. Effects of atenolol and propranolol on platelet aggregation in moderate essential hypertension: Randomized crossover trial. Croat Med J. 2005; 46: 219-224.
134. Winther K, Trap-Jensen J,. Effects of three beta-blockers with different pharmacodynamic properties on platelet aggregation and platelet and plasma cyclic AMP. Eur J Clin Pharmacol. 1988; 35: 17-20.
135. Brandt R, Seppala E, Nowak J, Vapaatalo H,. Effect of propranolol, practolol and atenolol on human platelet thromboxane formation and plasma levels of prostaglandins 6-keto-F1 alpha and E2. Prostaglandins Leukot Med. 1984; 16: 191-203.
136. Roth E, Matos G, Guarnieri C, Papp B, Varga J,. Influence of the beta-blocker therapy on neutrophil superoxide generation and platelet aggregation in experimental myocardial ischemia and reflow. Acta Physiol Hung. 1995; 83: 163-170.
137. Petrikova M, Jancinova V, Nosal R, Majekova M, Danihelova E,. Antiplatelet activity of carvedilol in comparison to propranolol. Platelets. 2002; 13: 479-485.
138. Jurgensen HJ, Dalsgaard-Nielsen J, Kjoller E, Gormsen J,. Effect of long-term beta-blockade with alprenolol on platelet function and fibrinolytic activity in patients with coronary heart disease. Eur J Clin Pharmacol. 1981; 20: 245-250.
139. Jones CR, Pasanisi F, Elliott HL, Reid JL,. Effects of verapamil and nisoldipine on human platelets: In vivo and in vitro studies. Br J Clin Pharmacol. 1985; 20: 191-196.
140. Okrucka A, Pechan J, Kratochvilova H,. Effects of the angiotensin-converting enzyme (ACE) inhibitor perindopril on endothelial and platelet functions in essential hypertension. Platelets. 1998; 9: 63-67.
141. Endo Y, Mamiya S, Miura AB,. Effects of riboflavin-2', 3', 4', 5'-tetrabutyrate on platelet function and plasma lipids. Jpn J Med. 1985; 24: 13-18.
142. Innes AJ, Kennedy G, McLaren M, Bancroft AJ, Belch JJ,. Dark chocolate inhibits platelet aggregation in healthy volunteers. Platelets. 2003; 14: 325-327.
143. Hibino T, Yuzurihara M, Terawaki K, Kanno H, Kase Y, Takeda A,. Goshuyuto, a traditional Japanese medicine for migraine, inhibits platelet aggregation in guinea-pig whole blood. J Pharmacol Sci. 2008; 108: 89-94.
144. Pakala R, Waksman R,. Currently available methods for platelet function analysis: Advantages and disadvantages. Cardiovasc Revasc Med. 2011; 12: 312-322.
145. Johnson GJ, Sharda AV, Rao GH, Ereth MH, Laxson DD, Owen WG,. Measurement of shear-activated platelet aggregate formation in non-anticoagulated blood: Utility in detection of clopidogrel-aspirin-induced platelet dysfunction. Clin Appl Thromb Hemost. 2012; 18: 140-149.
146. Markus HS, McCollum C, Imray C, Goulder MA, Gilbert J, King A,. The von Willebrand inhibitor ARC1779 reduces cerebral embolization after carotid endarterectomy: A randomized trial. Stroke. 2011; 42: 2149-2153.
147. Konstantopoulos K, Kamat SG, Schafer AI, et al,. Shear-induced platelet aggregation is inhibited by in vivo infusion of an anti-glycoprotein IIb/IIIa antibody fragment, c7E3 Fab, in patients undergoing coronary angioplasty. Circulation. 1995; 91: 1427-1431.
148. Gurbel PA, Bliden KP, Butler K, et al,. Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: The ONSET/OFFSET study. Circulation. 2009; 120: 2577-2585.
149. Cloud GC, Markus HS,. Diagnosis and management of vertebral artery stenosis. QJM. 2003; 96: 27-54.
150. Gawel M, Burkitt M, Rose FC,. The platelet release reaction during migraine attacks. Headache. 1979; 19: 323-327.
151. Takeshima T, Shimomura T, Takahashi K,. Platelet activation in muscle contraction headache and migraine. Cephalalgia. 1987; 7: 239-243.
152. Tietjen GE, Al Qasmi MM, Athanas K, Dafer RM, Khuder SA,. Increased von Willebrand factor in migraine. Neurology. 2001; 57: 334-336.
153. Zeller JA, Frahm K, Baron R, Stingele R, Deuschl G,. Platelet-leukocyte interaction and platelet activation in migraine: A link to ischemic stroke? J Neurol Neurosurg Psychiatry. 2004; 75: 984-987.
154. Sarchielli P, Alberti A, Coppola F, et al,. Platelet-activating factor (PAF) in internal jugular venous blood of migraine without aura patients assessed during migraine attacks. Cephalalgia. 2004; 24: 623-630.
155. Kitano A, Shimomura T, Takeshima T, Takahashi K,. Increased 11-dehydrothromboxane B2 in migraine: Platelet hyperfunction in patients with migraine during headache-free period. Headache. 1994; 34: 515-518.
156. Shimomura T, Murakami F, Kotani K, Ikawa S, Kono S,. Platelet nitric oxide metabolites in migraine. Cephalalgia. 1999; 19: 218-222.
157. Gallai V, Floridi A, Mazzotta G, et al,. L-arginine/nitric oxide pathway activation in platelets of migraine patients with and without aura. Acta Neurol Scand. 1996; 94: 151-160.
158. Buttinelli C, Lazzaro MP, Lenzi GL, Paolucci S, Prencipe M,. Correlation between migraine and circulating platelet aggregates. Cephalalgia. 1985; 5 (Suppl. 2): 87-88.
159. Deshmukh SV, Meyer JS, Mouche RJ,. Platelet dysfunction in migraine: Effect of self-medication with aspirin. Thromb Haemost. 1976; 36: 319-324.
160. Carrieri P, Sorge F, Orefice G, De Feo S,. Platelet function in childhood migraine. Cephalalgia. 1985; 5 (Suppl. 2): 99-101.
161. Bensenor IM, Cook NR, Lee IM, Chown MJ, Hennekens CH, Buring JE,. Low-dose aspirin for migraine prophylaxis in women. Cephalalgia. 2001; 21: 175-183.
162. Buring JE, Peto R, Hennekens CH,. Low-dose aspirin for migraine prophylaxis. JAMA. 1990; 264: 1711-1713.
163. Diener HC, Hartung E, Chrubasik J, et al,. A comparative study of oral acetylsalicyclic acid and metoprolol for the prophylactic treatment of migraine. A randomized, controlled, double-blind, parallel group phase III study. Cephalalgia. 2001; 21: 120-128.
164. Masel BE, Chesson AL, Peters BH, Levin HS, Alperin JB,. Platelet antagonists in migraine prophylaxis. A clinical trial using aspirin and dipyridamole. Headache. 1980; 20: 13-18.
165. Allais G, D'Andrea G, Airola G, De Lorenzo C, Mana O, Benedetto C,. Picotamide in migraine aura prevention: A pilot study. Neurol Sci. 2004; 25 (Suppl. 3): S267-S269.
166. Tomita H, Hatakeyama K, Soda W, Kobayashi T,. Efficacy of ticlopidine for preventing migraine after transcatheter closure of atrial septal defect with Amplatzer septal occluder: A case report. J Cardiol. 2007; 49: 357-360.
167. Bousser MG, Conard J, Lecrubier C, Bousser J,. [Migraine or transient ischemic attacks in a patient with essential thrombocythaemia. Treatment with ticlopidine (author's transl)]. Ann Med Interne (Paris). 1980; 131: 87-90.
168. Hsu DA, Stafstrom CE, Rowley HA, Kiff JE, Dulli DA,. Hemiplegic migraine: Hyperperfusion and abortive therapy with intravenous verapamil. Brain Dev. 2008; 30: 86-90.
169. Friberg L, Olesen J, Iversen HK, Sperling B,. Migraine pain associated with middle cerebral artery dilatation: Reversal by sumatriptan. Lancet. 1991; 338: 13-17.
170. Elkind AH, Friedman AP, Grossman J,. Cutaneous blood flow in vascular headaches of the migraine type. Neurology. 1964; 14: 24-30.
171. Raieli V, Monastero R, Santangelo G, Eliseo GL, Eliseo M, Camarda R,. Red ear syndrome and migraine: Report of eight cases. Headache. 2002; 42: 147-151.
172. Raieli V, Compagno A, Brighina F, et al,. Prevalence of red ear syndrome in juvenile primary headaches. Cephalalgia. 2011; 31: 597-602.
173. O'Brien MD,. Cerebral blood changes in migraine. Headache. 1971; 10: 139-143.
174. Sakai F, Meyer JS,. Regional cerebral hemodynamics during migraine and cluster headaches measured by the 133Xe inhalation method. Headache. 1978; 18: 122-132.
175. Meyer JS, Zetusky W, Jonsdottir M, Mortel K,. Cephalic hyperemia during migraine headaches. A prospective study. Headache. 1986; 26: 388-397.
176. Andersen AR, Friberg L, Olsen TS, Olesen J,. Delayed hyperemia following hypoperfusion in classic migraine. Single photon emission computed tomographic demonstration. Arch Neurol. 1988; 45: 154-159.
177. Sanchez DR, Bakker D, Wu O, et al,. Perfusion weighted imaging during migraine: Spontaneous visual aura and headache. Cephalalgia. 1999; 19: 701-707.
178. Kato Y, Araki N, Matsuda H, Ito Y, Suzuki C,. Arterial spin-labeled MRI study of migraine attacks treated with rizatriptan. J Headache Pain. 2010; 11: 255-258.
179. Pollock JM, Deibler AR, Burdette JH, et al,. Migraine associated cerebral hyperperfusion with arterial spin-labeled MR imaging. AJNR Am J Neuroradiol. 2008; 29: 1494-1497.
180. Weiller C, May A, Limmroth V, et al,. Brain stem activation in spontaneous human migraine attacks. Nat Med. 1995; 1: 658-660.
181. Afridi SK, Giffin NJ, Kaube H, et al,. A positron emission tomographic study in spontaneous migraine. Arch Neurol. 2005; 62: 1270-1275.
182. Woods RP, Iacoboni M, Mazziotta JC,. Brief report: Bilateral spreading cerebral hypoperfusion during spontaneous migraine headache. N Engl J Med. 1994; 331: 1689-1692.
183. Denuelle M, Fabre N, Payoux P, Chollet F, Geraud G,. Posterior cerebral hypoperfusion in migraine without aura. Cephalalgia. 2008; 28: 856-862.
184. Olesen J, Friberg L, Olsen TS, et al,. Ischaemia-induced (symptomatic) migraine attacks may be more frequent than migraine-induced ischaemic insults. Brain. 1993; 116: 187-202.
185. Solomon S, Lipton RB, Harris PY,. Arterial stenosis in migraine: Spasm or arteriopathy? Headache. 1990; 30: 52-61.
186. Micieli G, Bosone D, Tassorelli C, Zappoli F, Castellano AE, Nappi G,. Internal carotid occlusion associated with migraine syndrome: A case study of a 22-year-old female. Funct Neurol. 1996; 11: 45-51.
187. Masuzawa T, Shinoda S, Furuse M, Nakahara N, Abe F, Sato F,. Cerebral angiographic changes on serial examination of a patient with migraine. Neuroradiology. 1983; 24: 277-281.
188. Cole AJ, Aube M,. Migraine with vasospasm and delayed intracerebral hemorrhage. Arch Neurol. 1990; 47: 53-56.
189. Iu PP, Lam HS,. Migrainous spasm simulating carotid dissection: A pitfall in MR arteriographic findings. AJNR Am J Neuroradiol. 2001; 22: 1550-1552.
190. Boasso LE, Fischer AQ,. Cerebral vasospasm in childhood migraine during the intermigrainous period. J Neuroimaging. 2004; 14: 158-161.
191. Lovrencic-Huzjan A, Demarin V, Rundek T, Vukovic V,. Role of vertebral artery hypoplasia in migraine. Cephalalgia. 1998; 18: 684-686.
192. Chuang YM, Hwang YC, Lin CP, Liu CY,. Toward a further elucidation: Role of vertebral artery hypoplasia in migraine with aura. Eur Neurol. 2008; 59: 148-151.
193. Monteiro JM, Rosas MJ, Correia AP, Vaz AR,. Migraine and intracranial vascular malformations. Headache. 1993; 33: 563-565.
194. Waltimo O, Hokkanen E, Pirskanen R,. Intracranial arteriovenous malformations and headache. Headache. 1975; 15: 133-135.
195. Ramadan NM, Tietjen GE, Levine SR, Welch KM,. Scintillating scotomata associated with internal carotid artery dissection: Report of three cases. Neurology. 1991; 41: 1084-1087.
196. Silverman IE, Wityk RJ,. Transient migraine-like symptoms with internal carotid artery dissection. Clin Neurol Neurosurg. 1998; 100: 116-120.
197. Buttinelli C, Spalloni A, Fieschi C, Rasura M,. Migraine and arterial dissection in a young woman. Neurol Sci. 2001; 22: 275-278.
198. Duyff RF, Snijders CJ, Vanneste JA,. Spontaneous bilateral internal carotid artery dissection and migraine: A potential diagnostic delay. Headache. 1997; 37: 109-112.
199. d'Anglejan CJ, Ribeiro V, Mas JL, Bousser MG, Laplane D,. Dissection of the extracranial internal carotid artery. 62 cases. Presse Med. 1990; 19: 661-667.
200. Rist PM, Diener HC, Kurth T, Schurks M,. Migraine, migraine aura, and cervical artery dissection: A systematic review and meta-analysis. Cephalalgia. 2011; 31: 886-896.
201. Rubinstein SM, Peerdeman SM, van Tulder MW, Riphagen I, Haldeman S,. A systematic review of the risk factors for cervical artery dissection. Stroke. 2005; 36: 1575-1580.
202. Rosenblum WI, El Sabban F, Allen AD, Nelson GH, Bhatnagar AS, Choi SC,. Effects of estradiol on platelet aggregation in cerebral microvessels of mice. Stroke. 1985; 16: 980-984.
203. Sasaki T, Ohno Y, Otsuka K, Suzawa T, Suzuki H, Saruta T,. Oestrogen attenuates the increases in blood pressure and platelet aggregation in ovariectomized and salt-loaded Dahl salt-sensitive rats. J Hypertens. 2000; 18: 911-917.
204. Huch KM, Elam MB, Chesney CM,. Oral contraceptive steroid induced platelet coagulant hyperactivity: Dissociation of in vivo and in vitro effects. Thromb Res. 1987; 48: 41-50.
205. Rosenblum WI, El Sabban F, Nelson GH,. One day of estradiol treatment enhances platelet aggregation at the site of microvascular injury without altering aggregation ex vivo. Life Sci. 1988; 42: 123-128.
206. Naesh O, Haedersdal C, Hindberg I, Trap-Jensen J,. Platelet activation in mental stress. Clin Physiol. 1993; 13: 299-307.
207. Wallen NH, Held C, Rehnqvist N, Hjemdahl P,. Effects of mental and physical stress on platelet function in patients with stable angina pectoris and healthy controls. Eur Heart J. 1997; 18: 807-815.
208. Kawahara J, Sano H, Fukuzaki H, Saito K, Hirouchi H,. Acute effects of exposure to cold on blood pressure, platelet function and sympathetic nervous activity in humans. Am J Hypertens. 1989; 2: 724-726.
209. Hutton RA, Mikhailidis D, Dormandy KM, Ginsburg J,. Platelet aggregation studies during transient hypoglycaemia: A potential method for evaluating platelet function. J Clin Pathol. 1979; 32: 434-438.
210. Dechavanne M,. Influence of diet and life habits on platelet functions. Rev Prat. 1989; 39: 2223-2227.
211. Nara Y, Kihara M, Nabika T, Mano M, Horie R, Yamori Y,. Dietary effect on platelet aggregation in men with and without a family history of essential hypertension. Hypertension. 1984; 6: 339-343.
212. Morrell CN, Sun H, Ikeda M, et al,. Glutamate mediates platelet activation through the AMPA receptor. J Exp Med. 2008; 205: 575-584.
213. Grosser K, Oelkers R, Hummel T, et al,. Olfactory and trigeminal event-related potentials in migraine. Cephalalgia. 2000; 20: 621-631.